James Wheless, MD: Neurology, Epilepsy, and COVID-19

May 28, 2020


Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.

Comparing Continuous to Brief Intermittent EEG for Detecting Ictal Activity

April 29, 2020


Brief intermittent EEG may not have enough sensitivity for detecting potentially treatable seizures in cardiac arrest patients who required resuscitation.

Epilepsy Drug Reduces Anxiety and Insomnia Symptoms

April 23, 2020


New data finds perampanel lowers Insomnia Severity Index scores in patients.

ESETT Trial Finds 3 Anti-Seizure Treatments Equally Safe, Effective

November 28, 2019


Results of the ESETT trial are revealing there is little difference in the effectiveness or safety profiles of three anti-seizure treatments for patients with a severe form epilepsy.

FDA Approves Cenobamate for Partial-Onset Seizures

November 22, 2019


The once-daily oral therapy is recommended at a 200 mg dose, following titration.

Prenatal Antiepileptic Drug Exposure Associated with Childhood Behavior Issues

June 07, 2019


Children exposed in utero to valproate were most affected, but exposure to 3 other monotherapies were also associated with behavioral issues.

FDA Approves Anti-Epileptic Nasal Spray

May 20, 2019


FDA approved midazolam nasal spray for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity distinct from a patient's usual seizure pattern in patients with epilepsy 12 years of age and older.

Managing Epilepsy and Seizures in the Emergency Department

March 14, 2019


How can emergency department doctors best be prepared to identify and treat seizures in the ER?